Dogs Of The Dow: Top 10 High-Yield Stock, Amgen Inc. AMGN, Offering Dividends Up To 6.8 In 2025

January 01, 2025

Amgen Inc. (AMGN) is emerging as one of the top pharmaceutical companies in terms of dividend stocks. With a strong focus on innovation and research, the company has been able to deliver consistent revenue growth over the years.

In recent market fluctuations, Amgen Inc. has shown resilience and continues to advance while the overall market declines. Despite challenges faced by the industry, the company has managed to navigate through them successfully.

Investors looking for stable dividend stocks should consider adding Amgen Inc. to their portfolio. The company has a track record of providing attractive dividends and is expected to offer dividends of up to 6.8 in 2025.

Amgen Inc.'s commitment to its shareholders is evident through its consistent dividend payments. With a strong pipeline of products and ongoing research, the company is well-positioned for future growth.

For expert analysis and a comprehensive forecast on the movement of Amgen Inc. stocks, it is recommended to consult professionals from Stocks Prognosis. They provide valuable insights and guidance for investors seeking to capitalize on the potential of this leading pharmaceutical company.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

I have faith in Amgen Inc.'s ability to navigate the challenges of the pharmaceutical industry. Their consistent revenue growth is a testament to their strong business strategy

— from FinanceFlo at 01-04-2025 19:47

I've been a shareholder of Amgen Inc. for a while now and I'm glad to see their resilience in the market. It's comforting to know that my investment is in good hands

— from GabrielFoster at 01-04-2025 19:39

Amgen Inc.'s resilience in the face of market fluctuations is impressive. It shows that the company is well-managed and will likely continue to thrive in the future

— from CashCasey at 01-04-2025 15:06

I'm not convinced that Amgen Inc. can sustain its dividend growth. The pharmaceutical industry is highly competitive and subject to constant change. It's hard to predict how they will perform in the long run

— from InvestorImogen at 01-03-2025 23:45

I'm excited about the potential dividends of up to 6.8 in 2025. Amgen Inc. seems like a reliable investment choice with its strong focus on research and consistent revenue growth

— from LilyPerez at 01-03-2025 22:31

I've heard great things about Amgen Inc.'s research and development efforts. Their commitment to innovation makes me confident in their potential for future growth

— from RileyHughes at 01-03-2025 22:13

I'm excited to see the potential dividends of up to 6.8 in 2025. Amgen Inc. seems like a promising investment option for long-term gains

— from AnnaDuncan at 01-03-2025 18:50

Amgen Inc. has always been a reliable stock for dividends. I've been a consistent shareholder for years and I'm glad to see their commitment to providing attractive dividends continue

— from EmilyMiller at 01-03-2025 12:54

I trust Stocks Prognosis for reliable analysis and forecast. I will definitely consult with them to get a better understanding of Amgen Inc.'s potential as an investment

— from AdamWells at 01-03-2025 12:19

I'm considering diversifying my portfolio with pharmaceutical stocks and Amgen Inc. seems like a great option. I will definitely look into their financials and growth prospects

— from IsaacPerry at 01-03-2025 09:48

I trust the experts at Stocks Prognosis for accurate analysis. I will definitely consult with them to gain more insights into Amgen Inc.'s potential as an investment

— from CalebBishop at 01-03-2025 03:31

I've been following Amgen Inc. for a while now and their dedication to research and development is commendable. I'm confident in their ability to deliver consistent revenue growth

— from WilliamReed at 01-03-2025 02:02

Amgen Inc.'s commitment to innovation and research sets them apart from other pharmaceutical companies. I'm confident that their strong focus on these areas will lead to future success

— from MatthewGarcia at 01-03-2025 00:34

I'm not sure if I should trust pharmaceutical companies for long-term investment. The industry is highly regulated and subject to unexpected setbacks. I'll wait for more information before making a decision

— from WealthyWanda at 01-02-2025 18:39

I'm interested to learn more about Amgen Inc. and how its strong focus on innovation sets it apart from other pharmaceutical companies. Can you provide more information about their research pipeline?

— from CashMike at 01-02-2025 17:14

I'm curious to know more about Amgen Inc.'s pipeline of products. Are they focused on any specific therapeutic areas or do they have a diverse portfolio?

— from JosephMorris at 01-02-2025 13:21

I'm hesitant to invest in pharmaceutical companies due to the regulatory risks involved. One negative FDA approval could significantly impact Amgen Inc.'s stock performance

— from NoraJenkins at 01-02-2025 13:06

This is great news! Amgen Inc. seems like a solid investment with its consistent revenue growth and attractive dividends. I will definitely look into adding it to my portfolio

— from FinanceFinn at 01-02-2025 05:48

Can you provide more information on Amgen Inc.'s revenue growth over the years? I'm particularly interested in their performance during economic downturns

— from ProfitPiper at 01-02-2025 05:01

Amgen Inc.'s track record of strong dividend payments is definitely a plus. It's a good sign that they prioritize their shareholders and aim to provide attractive returns

— from GrowthGina at 01-01-2025 17:46

If you want to leave a comment, then you need Login or Register

Other news for AMGN

April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

Related news

December 4, 2024AbbVie Inc.: A Profitable Pharmaceutical Stock to Consider ~2 min.

AbbVie Inc. (ABBV) is one of the most profitable pharmaceutical stocks in the market right now....

March 15, 2025Shareholders that lost money on GSK plc GSK Urged to Join Class Action ~2 min.

GSK plc, also known as GlaxoSmithKline, is facing a potential class action lawsuit from shareholders who have suffered financial losses....

January 1, 2025Stocks Prognosis: Is AstraZeneca PLC AZN Set to Become a U.K. Dividend Champion by 2024? ~2 min.

AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....

January 5, 2025GSK Plc's Strong Returns and Updates on Voting Rights and Capital Structure ~1 min.

GSK plc, a leading pharmaceutical company, continues to deliver strong returns to its shareholders....

January 2, 2025Regeneron Pharmaceuticals Continues to Impress Investors with Strong Returns ~1 min.

In the past five years, Regeneron Pharmaceuticals (NASDAQ:REGN) has delivered a solid return of 89%, making it a favorable choice for investors....

Search on StockPrognosis.com

Sections of the site

Dogs Of The Dow: Top 10 High-Yield Stock, Amgen Inc. AMGN, Offering Dividends Up To 6.8 In 2025

Find out how the AMGEN INC. rate is expected to change

Investor opinions & comments:

Other news for AMGN

Related news

Stocks-Prognosis.com © 2025